XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning of the period at Mar. 31, 2020 $ 1,489,268 $ (553) $ 30,148 $ 75,097 $ (185,896) $ 1,690,579 $ (553) $ (120,660)
Beginning of the period (in shares) at Mar. 31, 2020     173,106   6,210      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 340,795         338,987   1,808
Purchases of registered shares (22,454)       $ (22,454)      
Purchase of registered shares (in shares)         312      
Sales of shares upon exercise of stock options and purchase rights 26,066     1,365 $ 24,701      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (1,211)      
Issuance of shares upon vesting of restricted stock units (25,744)     (43,135) $ 17,391      
Issuance of shares upon vesting of restricted stock units (in shares)         (954)      
Share-based compensation 45,290     45,290        
Cash dividends (146,705)         (146,705)    
End of the period at Sep. 30, 2020 1,705,963   $ 30,148 78,617 $ (166,258) 1,882,308   (118,852)
End of the period (in shares) at Sep. 30, 2020     173,106   4,357      
Beginning of the period at Jun. 30, 2020 1,567,481   $ 30,148 54,668 $ (158,463) 1,762,099   (120,971)
Beginning of the period (in shares) at Jun. 30, 2020     173,106   4,689      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 269,033         266,914   2,119
Purchases of registered shares (22,454)       $ (22,454)      
Purchase of registered shares (in shares)         312      
Sales of shares upon exercise of stock options and purchase rights 16,074     3,255 $ 12,819      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (568)      
Issuance of shares upon vesting of restricted stock units (2,623)     (4,463) $ 1,840      
Issuance of shares upon vesting of restricted stock units (in shares)         (76)      
Share-based compensation 25,157     25,157        
Cash dividends (146,705)         (146,705)    
End of the period at Sep. 30, 2020 1,705,963   $ 30,148 78,617 $ (166,258) 1,882,308   (118,852)
End of the period (in shares) at Sep. 30, 2020     173,106   4,357      
Beginning of the period at Mar. 31, 2021 2,261,789   $ 30,148 129,519 $ (279,541) 2,490,578   (108,915)
Beginning of the period (in shares) at Mar. 31, 2021     173,106   4,799      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 324,193         326,297   (2,104)
Purchases of registered shares (174,380)       $ (174,380)      
Purchase of registered shares (in shares)         1,656      
Sales of shares upon exercise of stock options and purchase rights 16,636     8,389 $ 8,247      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (226)      
Issuance of shares upon vesting of restricted stock units (54,751)     (87,080) $ 32,329      
Issuance of shares upon vesting of restricted stock units (in shares)         (898)      
Share-based compensation 48,606     48,606        
Cash dividends (159,410)         (159,410)    
End of the period at Sep. 30, 2021 2,262,683   $ 30,148 99,434 $ (413,345) 2,657,465   (111,019)
End of the period (in shares) at Sep. 30, 2021     173,106   5,331      
Beginning of the period at Jun. 30, 2021 2,372,491   $ 30,148 74,948 $ (302,606) 2,677,419   (107,418)
Beginning of the period (in shares) at Jun. 30, 2021     173,106   4,407      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 135,855         139,456   (3,601)
Purchases of registered shares (119,508)       $ (119,508)      
Purchase of registered shares (in shares)         1,151      
Sales of shares upon exercise of stock options and purchase rights 13,886     8,168 $ 5,718      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (155)      
Issuance of shares upon vesting of restricted stock units (4,340)     (7,391) $ 3,051      
Issuance of shares upon vesting of restricted stock units (in shares)         (72)      
Share-based compensation 23,709     23,709        
Cash dividends (159,410)         (159,410)    
End of the period at Sep. 30, 2021 $ 2,262,683   $ 30,148 $ 99,434 $ (413,345) $ 2,657,465   $ (111,019)
End of the period (in shares) at Sep. 30, 2021     173,106   5,331